Old Web
English
Sign In
Acemap
>
authorDetail
>
Ben Breton
Ben Breton
Medicine
Epitope
Oncology
Immunogenicity
Pembrolizumab
3
Papers
29
Citations
0.00
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (2)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
A phase I multicenter study to assess the safety, tolerability, and immunogenicity of mRNA-4157 alone in patients with resected solid tumors and in combination with pembrolizumab in patients with unresectable solid tumors.
2019
Journal of Clinical Oncology
Howard A. Burris
Manish R. Patel
Daniel C. Cho
Jeffrey Melson Clarke
Martin Gutierrez
Tal Z. Zaks
Joshua Frederick
Kristen Hopson
Kinjal Mody
Alverina Binanti-Berube
Céline Robert-Tissot
Bree Goldstein
Ben Breton
Jing Sun
Shan Zhong
Scott K. Pruitt
Karen N. Keating
Robert S. Meehan
Justin F. Gainor
Show All
Source
Cite
Save
Citations (24)
A phase 1, open-label, multicenter study to assess the safety, tolerability, and immunogenicity of mRNA-4157 alone in subjects with resected solid tumors and in combination with pembrolizumab in subjects with unresectable solid tumors (Keynote-603).
2019
Journal of Global Oncology
Howard A. Burris
Manish R. Patel
Daniel C. Cho
Jeffrey Melson Clarke
Martin Gutierrez
Tal Z. Zaks
Joshua Frederick
Kristen Hopson
Kinjal Mody
Alverina Binanti-Berube
Céline Robert-Tissot
Kristen Cowens
Ben Breton
Shan Zhong
Honghong Zhou
Pamela Sarah Cohen
Karen N. Keating
Robert S. Meehan
Justin F. Gainor
Show All
Source
Cite
Save
Citations (5)
1